Summary.-The NCA (nonspecific cross-reacting antigen) was assayed in sera of patients with chronic myeloid leukaemia (CML). It was elevated to a mean value of 145.6 ng/ml (± 104-4 ng/ml) compared to 37-8 ng/ml (± 14-6 ng/ml) the sera of normal subjects. Patients with active disease generally had higher serum NCA levels than those with CML in blast crisis. A correlation of the serum NCA levels with the cellular contents of this antigen was attempted using different methods. Large variations of serum NCA levels were observed in different patients having roughly similar white blood cell (WBC) counts. In general a better correlation was observed between the serum NCA level and the number of maturing myeloid cells than with the number of polymorphs. The staining of blood smears with anti-NCA serum by an immunoperoxidase method suggested an explanation for some cases of CML in blast crisis with normal serum NCA levels inasmuch as the staining of myeloid cells was very weak or negative in these cases, indicative of a lack of NCA synthesis in the cells. In other cases, cellular NCA was measured by radioimmunoassay in maturing myeloid cells and polymorphs. The mean values were not significantly different from the NCA values obtained in normal polymorphs. From the NCA content/106 cells and the polymorph or maturing myeloid cell counts, we calculated the total NCA cell content/ml of blood. It was much higher than, though poorly correlated with, the serum NCA level. Thus factors other than NCA cellular content, mainly the rate of NCA release from the myeloid cells, might play an important role in the regulation of its serum level.
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THE NONSPECIFIC cross-reacting antigen (NCA) has been described by different authors (Mach & Pusztaszeri, 1972; Newman et al., 1972; von Kleist et al, 1972; Darcy et al., 1973) . This antigen bears common antigenic determinants with carcinoembryonic antigen (CEA), but it also has unique determinants so that it is possible to prepare specific antisera against it. A quite similar cell and tissue localization to that of CEA has been demonstrated by immunofluorescence in normal and gastrointestinal tissues . NCA has also been found in alveolar macrophages, in normal polymorphs from peripheral blood (Bordes et al. 1975; Burtin et al., 1975) , and in precursor cells of normal and pathological myeloid series . NCA has been assayed in normal and pathological sera using radioimmunological methods (Edgington et al., 1976; von Kleist et at., 1977a, b) . We also demonstrated (Frenoy & Burtin, 1980) that the serum NCA level was decreased in acute myeloid leukaemia (AML) and highly increased in patients with chronic myeloid leukaemia (CML).
In the present study, a higher number of CML patients was studied and we have confirmed our initial results. However, the NCA level, although generally high, was quite variable in CML patients. In order to find an explanation for this variability, we investigated clinical and histological parameters, such as the stage of the disease, the white blood cell (WBC) and polymorph counts and the NCA cellular content.
We also obtained some indication of the rate of NCA release from the cells into the plasma. The stage of the disease at the monrent of sampling was known for 63 patients, and 9 patients were studied longitudinally.
Preparation of pure NCA and labelling.
NCA was prepared from perchloric extracts of normal lung and the purity of the preparation was checked as previously described (Burtin & Chavanel, 1973) . The labelling with 125I was made by the chloramine T method of Hunter & Greenwood (1964) and gave a radiolabelled NCA with a specific activity around 35 tuCi/,tg.
Anti-NCA serum.-Anti-NCA serum was prepared in rabbits. They were immunized by 2 injections in the foot pads of 70 ,ug of NCA emulsified in complete Freund's adjuvant separated by 2 weeks. Animals were exsanguinated 2 weeks after the last injection. Controls for the monospecificity of the antiserum were conducted as previously described (Frenoy & Burtin, 1980) . NCA assay.-The NCA radioimmunoassay, using the double-antibody technique (Egan et al., 1972) has been described elsewhere (Frenoy & Burtin, 1980) . The anti-NCA serum was used at a dilution of 1/30,000. Assays were made twice in duplicate and sera were reassayed after dilution when NCA concentrations were > 80 ng/ml.
Cell material.-WBC were obtained from heparinized blood of CML patients (Blood Bank of St Louis Hospital) after sedimentation at 37°C. Mononuclear (mainly immature granulocytic cells in CML patients) and polymorph fractions were separated using centrifugation on Ficoll-Isopaque (Pharmacia, Uppsala, Sweden).
Cells were then counted and one part of each fraction was used immediately for the preparation of smears by cytocentrifugation (Cytospin-Shandon).
Preparation of cell ly8ates.-The other part of each fraction was frozen and, after thawing, sonicated to obtain a complete lysis and NCA liberation. NCA was assayed in the cellular supernatants obtained by ultracentrifugation in a Spinco ultracentrifuge (30 min at 30,000 rev/min in a 50 TI rotor) without further extraction.
Immunoperoxidase studies.-For immunoperoxidase studies, smears were incubated with anti-NCA serum, then with peroxidaselabelled sheep anti-rabbit globulin (Nordic) and stained with a mixture of amino-ethyl carbazole and H202 prepared according to Graham et al. (1965 (ng/ml).
Results are reported in Table I . The mean values between the 2 groups were significantly different (t= 4 878).
(2) Longitudinal studies Nine patients were studied over long periods. They generally gave a rough parallelism between serum NCA level and WBC number, and a better one between NCA and polymorph counts. The correlation with maturing myeloid cells was not studied in these cases, as the number of these cells was low due to chemotherapy.
Three cases were closely studied (Figs 2-4). Figs 2 and 4 illustrate a fairly good correlation between NCA and WBC number for the same subject. However, the inter-subject correlation was poor. The patient illustrated in Fig. 3 showed an intermittent correlation and cyclical changes of serum NCA level over a long period did not apparently correlate with WBC and polymorph counts.
(3) Study of the correlation between serum NCA concentration and white blood cell (or granulocytic cells) number
The relationship of NCA level to WBC, polymorphs and maturing myeloid cells was studied in the whole CML group and in the 2 subsets. Results are summarized in Table II. The correlation between NCA level and total WBC number was better when the whole CML group was studied. In all the cases, the correlation was better between serum NCA level and maturing myeloid cell number, but no coefficient of correlation exceeded 0-60.
(4) Reactivity of myeloid cells with anti-NCA serum. Immunoperoxidase study Sixteen patients were studied, blood smears were prepared and sera taken at the same time. These patients had marked leucocytosis between 40,000 and 515,000 WBC/mm3.
Two patients in blast crisis were taken among those investigated in the longitudinal studies and were followed for a long period. Their cells showed a weak or negative staining and at the same time a normal serum NCA level was found, contrasting with the elevated WBC count (37 ng/ml for 69,000 WBC/mm3 and 47 ng/ml for 40,000 WBC/mm3).
The 14 other patients were in active phase, with a high proportion of immature cells in their blood. For these patients, serum and blood were obtained and mononuclear cells and polymorphs were all the polymorphs (2-20 tg/ml) were much higher than serum NCA level (66-458 ng/ml).
We examined the correlation between total cellular content and serum NCA level in these 17 CML patients. The correlation was better between serum level and maturing myeloid cell content (r = 0 448), All than between serum level and polymorph um content (r = 04118), but the significance was weak even in the first comparison im-(P=O-10). ned eriells ,her Len, Itly igly ier-
DISCUSSION
The results described here for CML patients reinforce our previous conclusions. CML patients generally had higher serum NCA levels than normal subjects; however mean values were lower than those published by others (Wahren et al., 1980) . If these variations can at best be only partially explained by the NCA concentrations in myeloid cells, then other hypotheses have to be considered. The first explanation is the possible contribution of other cells which are known to contain NCA such as alveolar macrophages (Burtin et al., 1975) , monocytes (Burtin & Fondaneche, 1981), s.d. or epithelial cells of the gastrointestinal mucosa . However, it is likely that in CML patients the main source of NCA is the granulocytic cells.
Another possible explanation lies in the rate of NCA release from cells and the rate of NCA catabolism. Here we have recourse to experience with CEA; for example the very high levels of serum CEA found in medullary carcinomas of the thyroid could be explained by the release of CEA from the basal pole of cancerous cells into the connective tissue, then into the peripheral blood (Burtin et al., 1979) . In contrast, breast tumours generally contain intracytoplasmic CEA (von Kleist, 1980) , which fails to enter the blood, and serum CEA is normal or only weakly elevated. Thus high tissue concentrations of the same antigen may lead to very different serum levels, due to parameters such as the release rate. In common with NCA, the cellular amount of this antigen is several 100-fold higher than its serum level. Thus it is easy to understand how a small variation in the rate of NCA release may greatly influence the serum level of this antigen.
We have studied NCA release from the granulocytic cells of normal subjects and CML patients under non-physiological conditions in vitro. These appear to demonstrate that NCA release is slow in both categories, and extremely variable from one subject to another.
If this variability exists also in vivo, it could explain, at least in part, the intersubject variation of serum NCA levels reported herein.
